Given the performance to date, im going to take it as a good thing. Carl is no doubt an experienced and talented exec but doesnt seem to have helped us much. Things could have been worse of course, but could they have been much worse???? Im going to remain optimistic and hold. From what i can see from some other medical stocks, markets are reopening so last quarter will be interesting. Maybe the tyranny of distance and closed boarders took it toll on driving growth.
Given the performance to date, im going to take it as a good...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
